Replies to post #118006 on Savvy Trades and Investments

[researcher59]

MD (15.21) has been a single digit PE stock the past 2 1/2 years on declining EPS and missed estimates. One or two good quarters justifies a 10+ multiple, but they need to string together a few more earnings beats to increase the valuation. I'm holding, not adding.